Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8778713427f3c00296d87dcb061a063e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2013-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5294ac0705c30cc3215fd9e79d04dbb7 |
publicationDate |
2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013323245-A1 |
titleOfInvention |
Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
abstract |
This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107207603-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406686-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017149311-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016126719-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3253797-A4 |
priorityDate |
2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |